On the other hand, there are a range of activities by the pharmaceutical industry to develop antibiotics with potent activity against MRSA and increased safety profiles. Recent developments such ...

The mechanism behind how new antibiotics aimed at battling the superbug Methicillin-resistant Staphylococcus aureus (MRSA) function has been explained in a new study led by Shahriar Mobashery ...

When that happens, your infection will be said to be antibiotic resistant, and your physician will have to prescribe a different drug to combat it. MRSA: The Spread of Drug Resistance In fact ...

Superbug resistance is escalating within the clinical setting and community at large. In novative antibiotic strategies are still lacking within the pharmaceutical industry to keep pace with the ...

These work against a family of antibiotic known as gram-positive bacteria, which includes common superbugs Clostridium difficile and methicillin-resistant staphylococcus aureus (MRSA). They are used ...

The US accounts for 80% to 90% of the total market for anti-MRSA antibiotics, so FDA approval is key to growing ceftobiprole's revenues, currently a minor part of its CHF 131 million ($137 million ...

They found the mutated enzyme by examining one of the first samples of MRSA taken in the 1950s. We need antibiotics to be ... For the best stories in your inbox, click here.

Driven in part by the overuse and misuse of antibiotics in medicine and agriculture ... The Telegraph spoke to Vanessa Carter, who battled a recurrent MRSA infection that led to multiple ...

MRSA is frequently referred to as the hospital germ because it is particularly prevalent there as a result of the regular use of antibiotics. Other multi-resistant pathogens, however, pose a ...

First and foremost, it’s important to consult with your veterinarian to determine the cause of the infection and the best course of treatment. Additionally, some antibiotics may be more ...

The theory, though, is that the method could work for all sorts of bacteria, including MRSA and C ... Without a robust ...